Literature DB >> 19733212

Dopamine induces contraction in the proximal, but relaxation in the distal rat isolated small intestine.

Timo Kirschstein1, Fabian Dammann, Jenny Klostermann, Mirko Rehberg, Tursonjan Tokay, Rudolf Schubert, Rüdiger Köhling.   

Abstract

In the gut, dopamine is released by enteric neurons and modulates motility of small intestine smooth muscle cells. Here, we systematically analyzed the dopamine-induced effects on the longitudinal smooth muscle of different sections of the rat isolated small intestine. We found that exogenous dopamine had biphasic effects and could lead to both an early contraction and a late relaxation, depending on the region of small intestine. Thus, dopamine-induced early contractions were commonly observed in the duodenum, but less frequently in the jejunum, and rarely in the ileum. The amplitudes of these early contractions showed a striking regional dependence (duodenum>jejunum>ileum) and were significantly blocked by SCH23390 and raclopride. Conversely, dopamine-induced late relaxations were regularly obtained in the ileum and in the jejunum, but less frequently in the duodenum. Interestingly, the amplitudes of these relaxations showed an inverse regional dependence (ileum>jejunum>duodenum), and were insensitive to dopamine receptor antagonists. Rather, they were significantly inhibited by propranolol and prazosin. We conclude that dopamine exerts differential effects on smooth muscle motility in different regions within the rat small intestine. In proximal parts, dopamine predominantly causes D(1) and D(2) dopamine receptor-dependent contraction, whereas it leads to alpha and beta adrenoceptor-dependent relaxation in more distal parts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19733212     DOI: 10.1016/j.neulet.2009.08.080

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

1.  P2Y receptor-mediated transient relaxation of rat longitudinal ileum preparations involves phospholipase C activation, intracellular Ca(2+) release and SK channel activation.

Authors:  Felix Mader; Ludwig Krause; Tursonjan Tokay; Oliver W Hakenberg; Rüdiger Köhling; Timo Kirschstein
Journal:  Acta Pharmacol Sin       Date:  2016-03-28       Impact factor: 6.150

2.  Postnatal development of the dopaminergic signaling involved in the modulation of intestinal motility in mice.

Authors:  Maria Grazia Zizzo; Giacomo Cavallaro; Michelangelo Auteri; Gaetano Caldara; Ilaria Amodeo; Mariangela Mastropaolo; Domenico Nuzzo; Marta Di Carlo; Monica Fumagalli; Fabio Mosca; Flavia Mule; Rosa Serio
Journal:  Pediatr Res       Date:  2016-04-18       Impact factor: 3.756

3.  MitoPark transgenic mouse model recapitulates the gastrointestinal dysfunction and gut-microbiome changes of Parkinson's disease.

Authors:  Shivani Ghaisas; Monica R Langley; Bharathi N Palanisamy; Somak Dutta; Kirthi Narayanaswamy; Paul J Plummer; Souvarish Sarkar; Muhammet Ay; Huajun Jin; Vellareddy Anantharam; Arthi Kanthasamy; Anumantha G Kanthasamy
Journal:  Neurotoxicology       Date:  2019-09-07       Impact factor: 4.294

Review 4.  Contributions of Gut Bacteria and Diet to Drug Pharmacokinetics in the Treatment of Parkinson's Disease.

Authors:  Sebastiaan P van Kessel; Sahar El Aidy
Journal:  Front Neurol       Date:  2019-10-15       Impact factor: 4.003

5.  Mapping the Influence of the Gut Microbiota on Small Molecules across the Microbiome Gut Brain Axis.

Authors:  Heather Hulme; Lynsey M Meikle; Nicole Strittmatter; John Swales; Gregory Hamm; Sheila L Brown; Simon Milling; Andrew S MacDonald; Richard J A Goodwin; Richard Burchmore; Daniel M Wall
Journal:  J Am Soc Mass Spectrom       Date:  2022-03-09       Impact factor: 3.262

Review 6.  Molecular Mechanisms of Microbiota-Mediated Pathology in Irritable Bowel Syndrome.

Authors:  Yoshiyuki Mishima; Shunji Ishihara
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.